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Abstract
Background: The recent development of semi-automated techniques for stain-
ing and analyzing flow cytometry samples has presented new challenges. Quality
control and quality assessment are critical when developing new high throughput
technologies and their associated information services. Our experience suggests
that significant bottlenecks remain in the development of high throughput flow cy-
tometry methods for data analysis and display. Especially, data quality control and
quality assessment are crucial steps in processing and analyzing high throughput
flow cytometry data.
Methods: We propose a variety of graphical exploratory data analytic tools for
exploring ungated flow cytometry data. We have implemented a number of spe-
cialized functions and methods in the Bioconductor package rflowcyt. We demon-
strate the use of these approaches by investigating two independent sets of high
throughput flow cytometry data.
Results: We found that graphical representations can reveal substantial non-biological
differences in samples. Empirical Cumulative Distribution Function and summary
scatterplots were especially useful in the rapid identification of problems not iden-
tified by manual review.
Conclusions: Graphical exploratory data analytic tools are quick and useful means
of assessing data quality. We propose that the described visualizations should be
used as quality assessment tools and where possible, be used for quality control.
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Abstract
Background The recent development of semi-automated techniques for staining and analyzing
ﬂow cytometry samples has presented new challenges. Quality control and quality assessment
are critical when developing new high throughput technologies and their associated information
services. Our experience suggests that signiﬁcant bottlenecks remain in the development of high
throughput ﬂow cytometry methods for data analysis and display. Especially, data quality con-
trol and quality assessment are crucial steps in processing and analyzing high throughput ﬂow
cytometry data.
Methods We propose a variety of graphical exploratory data analytic tools for exploring un-
gated ﬂow cytometry data. We have implemented a number of specialized functions and methods
in the Bioconductor package rﬂowcyt. We demonstrate the use of these approaches by investi-
gating two independent sets of high throughput ﬂow cytometry data.
Results We found that graphical representations can reveal substantial non-biological diﬀer-
ences in samples. Empirical Cumulative Distribution Function and summary scatterplots were
especially useful in the rapid identiﬁcation of problems not identiﬁed by manual review.
Conclusions Graphical exploratory data analytic tools are quick and useful means of assessing
data quality. We propose that the described visualizations should be used as quality assessment
tools and where possible, be used for quality control.
Keywords ﬂow cytometry, high throughput, quality assessment, visualization, exploratory data
analysis, statistics, software
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Introduction
Traditionally, ﬂow cytometry (FCM) has been a tube-based technique limited to small-scale lab-
oratory and clinical studies. High throughput methods for FCM have recently been developed
for drug discovery and advanced research methods (1–4). As an example, ﬂow cytometry high
content screening (FC-HCS) can process up to a thousand samples daily at a single workstation,
and the results have been equivalent or superior to traditional manual multiparameter staining and
analysis techniques. The amount of information generated by high throughput technologies such
as FC-HCS need to be transformed into executive summaries which are brief enough for creative
studies by a human researcher (5). Quality control and quality assessment are crucial steps in the
development and use of new high throughput technologies and their associated information services
(5–7). Quality control in clinical cell analysis by FCM has been considered (8, 9). As an example,
Edwards et al. (9) proposed some quality scores for monitoring the quality of immunophenotyping
process (e.g., blood acquisition, cell preparation, lymphocyte staining). They showed that a low
degree of temporal parameter variation exits within individual whereas signiﬁcant variations can
exist between donors with respect to the parameter monitored. However little has been done with
high throughput FCM. For example, quality control of FCM experiments should include the as-
sessment of instrument parameters that aﬀect the accuracy and precision of data. In that respect,
Gratama et al. (10) have proposed some guidelines such as monitoring the ﬂuorescence measure-
ments by computing calibration plots for each ﬂuorescent parameter. However such procedures are
not yet systematically applied and data quality assessment is often needed to overcome a lack of
data quality control. The aim of data quality assessment is to detect whether any measurements
of any samples are substantially diﬀerent from the others, in ways that were not likely to be bi-
ologically motivated. The rationale is that such samples should be identiﬁed, investigated, and
potentially removed from any downstream analyses. Quality control, on the other hand, measures
such quantities during the assaying procedure and can alert the user to problems at a time where
they can be corrected.
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Data quality assessment in high throughput FCM experiment is complicated by the volume of
data involved and by the many processing steps required to produce those data. Each instrument
manufacturer has created software to drive the data acquisition process of the cytometer (e.g.,
CellQuest Pro by BD Biosciences, Summit by DakoCytomation or Expo32 by Beckman Coulter).
These tools are primarily designed for their proprietary instrument interface and oﬀer few, or no,
data quality assessment functions. Third party analysis and management tools, such as FlowJo
(Tree Star, Inc.), WinList (Verity Software House) or FCSExpress (Denovo Software) provide re-
searchers with more capable “oﬀ-line” analysis tools but remain limited in term of data quality
assessment.
We propose a number of one- and two-dimensional graphical methods for exploring the data in
the hope that they would be of some use to the investigators. The basis of our approach is that,
given a cell line, or a single sample, divided in several aliquots, the distribution of the same physi-
cal or chemical characteristics (e.g., side light scatter -SSC- or forward light scatter -FSC-) should
be similar between aliquots. To test this hypothesis, we made use of graphical exploratory data
analysis (EDA). Five distinct visualization methods were implemented to explore the distributions
and densities of ungated FCM data: Empirical Cumulative Distribution Function (ECDF) plots,
histograms, boxplots and two types of bivariate plots. These diﬀerent graphical methods should
provide investigators with diﬀerent views of the data. ECDF plots have been widely used in the
analysis of microarray data where they help to detect defective print tips, or plates of reagents that
have not been well handled (11). These plots can quickly reveal diﬀerences in the distributions, but
are not particularly useful for understanding the shape of a distribution. Histograms help to visu-
alize the shape of the distribution and can reveal structure, such as the mode. Boxplots summarize
the location of the distribution and can reveal asymmetry but are mainly applicable to unimodal
distributions. Boxplots are also commonly used in the processing of microarray data where they
help to identify hybridization artifacts and assess the need for between-array normalization to deal
4
http://biostats.bepress.com/bioconductor/paper11
with scale diﬀerences among diﬀerent arrays (11). Finally, we use bivariate plots representation in
two diﬀerent ways. In fact in some cases, when comparing two samples, we found two-dimensional
displays more informative, i.e., two-dimensional summaries can show diﬀerences in samples, while
the one-dimensional summaries, mentioned above, are similar. One common use of bivariate plots
in FCM experiments is to display the joint distribution of two continuous variables as dot plots
(e.g., FSC versus SSC). However the analysis of such dot plots might be a challenge as the high
density of plotted data points (an average of ten thousand data points per sample) might form a
blot and the frequency of the observations might not be easily appreciated. To overcome this issue
we propose to use contour plots where contour lines might be interpreted as the frequency of obser-
vations with respect to the x-y plane. The second use of bivariate plots, for high throughput FCM
data, is to render per well summary statistics for a particular plate in the format of a scatterplot.
In this view each point represents a single well and the x and y values are chosen to be various
summary statistics.
We illustrate the need and usefulness of those visualization tools to assess FCM data quality
through examination of two FC-HCS datasets. Our results demonstrate that the application of
these graphical analysis methods to ungated FCM data provides a systematic and eﬃcient method
of data quality assessment, preventing time-consuming gating and further analysis of unreliable
samples. Although the methods we propose are primarily aimed at the discovery of data quality
problems, they may detect diﬀerences that are biologically motivated. Hence, we discourage the
automatic removal of aberrant samples and emphasize the need to check whether such underlying
biological causes are present.
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Materials and Methods
The basis of our methodology is to compare diﬀerent samples, aliquots, or variables where few, if
any diﬀerences, should be observed. We propose to use visualization methods where it is easy to
detect departures from this anticipated behavior.
Flow Cytometry High Content Screening (FC-HCS)
The details of the FC-HCS technique have been published by Gasparetto et al. (2). In FC-HCS,
all procedures have been miniaturized so that small numbers of cells can be stained in 96-well
plates with ﬂuorescently conjugated antibodies using robotic ﬂuid handlers. Fluorescence acti-
vated cell sorter (FACS) analysis has been automated using a robotic device termed a Multiwell
Auto-Sampler (MAS, Becton Dickinson Corp.) that allows sample acquisition from 96-well plates.
FCM data acquisition was performed using MPM Flow (Becton Dickinson Corp.). FSC and SSC
parameters were recorded in linear mode and ﬂuorescent intensities were recorded in four decade log.
Graft versus Host Disease (GvHD) dataset
The FC-HCS technique was used to identify biomarkers that would predict the development of
GvHD; one of the most signiﬁcant clinical problems in the ﬁeld of allogeneic blood and marrow
transplantation. The GvHD dataset is a collection of weekly peripheral blood samples obtained
from 31 patients following allogeneic blood and marrow transplant. Samples were taken at vari-
ous time points before and after transplantation. On average, there were 14 (±3) time points per
patient, collected approximately every 10 days (±14). Samples were collected from 0 to 16 days
(average 6 ±4 days) before the transplantation and until 49 to 400 days (average 125 ±81 days)
after transplantation. Twenty-three diﬀerent cluster of diﬀerentiation (CD) were targeted to assess
immune cell lineages and functional states. At each time point, every patient blood sample was di-
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vided into eight to ten aliquots. Each aliquot was labeled with four diﬀerent ﬂuorescent probes and
the ﬂuorescent intensity of each biomarker was determined for at least ten thousand cells per sample.
Rituximab dataset
The Rituximab dataset is based on a FC-HCS screening of a 2000 compound chemical library
to identify agents that would enhance the anti-lymphoma activity of the therapeutic monoclonal
antibody Rituximab (2).
Daudi cells (derived from Human Burkitt Lymphoma) were placed in 96-well plates with 10 μM
BrDU. Samples were incubated for 12h and then two duplicate plates were prepared, one with com-
pound alone and one with 10μg/ml Rituximab. After incubation cells were harvested and stained
with anti-BrDU and 7-ADD. Cells were delivered directly from 96-well plates to a FACSCalibur
using a Microtiter Well Plate Device (BD Biosciences).
Graphical methods
We present ﬁve distinct visualization methods for exploring the densities of ungated FCM data: (i)
ECDF plots, (ii) histograms, (iii) boxplots, (iv) scatterplots of summary statistics and (v) contour
plots.
(i) ECDF plot shows the proportion of the observed data less than each x value, as a function of
x. ECDF plots were grouped by 96-well plate, time points and/or stains but can be grouped
by any other important variables.
(ii) A unity normalized histogram provides an estimate of the probability that a cell measurement
will fall into a particular channel. If one empirically measures values of a continuous random
variable repeatedly and produces a histogram depicting relative frequencies of output ranges,
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then this histogram will resemble the random variable’s probability density (assuming that
the variable is sampled suﬃciently often and the output ranges are suﬃciently narrow).
(iii) A boxplot, also known as a box-and-whisker diagram, is a one dimension reduction of a
distribution. The central box of the plot extends from the ﬁrst (25%) to the third quartile
(75%), with the median (50%) represented as a horizontal bar. Vertical lines (also called
whiskers) extend to 1.5 times the inter-quartile range, i.e., the box width from both ends of
the box (12).
(iv) Scatterplots of descriptive statistics were used to summarize the distribution of one or two
parameters of the diﬀerent samples stored in the same 96-well plate. The dots in the resulting
scatterplot can be colored according to their position in the 96-well plate (row or column
number). Either one descriptive statistic can be used to compare two diﬀerent variables (e.g.,
FSC versus SSC) or two descriptive statistics computed on the same variable, can be plotted.
Some proposed descriptive statistics are:
• mean: the arithmetic or average of a set of values, or distribution;
• median: the number such that at most half the population have values less than the
median and at most half have values greater than the median;
• mode: the value obtained by the largest number of observations in a distribution. The
mode is not necessarily unique, since the same maximum frequency may be attained at
diﬀerent values;
• interquartile range (IQR): the diﬀerence between the third and ﬁrst quartile of the dis-
tribution, 75% and 25% respectively. It is a measures of statistical dispersion.
The scatterplot function is implemented so that one can plot any of those statistical summary
against each other for a better exploration of the data.
(v) Contour plots can be used to compare values obtained per cell, on two variables. Since the
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number of data points is often very large we recommend using hexagonal binning or smoothing
techniques such as contour plots to enhance visual perception. Contour plots can be used
in combination with shaded colors which correspond to a range of values. They are often a
better way than dot plots or three-dimensional surface plots in the sense that it is easier to
estimate the population frequency from them.
Algorithms
The EDA tools and plotting functions were implemented in R (13). They are freely available as part
of the rﬂowcyt package, which is part of the Bioconductor project, an open source and open develop-
ment software project, for the analysis and comprehension of genomic data (http://www.bioconductor.org).
In addition to the described EDA tools, rﬂowcyt can import data from the FCS 2.0 and 3.0 ﬁles. It
provides a preliminary and programmatic interface for gating, computing post gating, distributional
tests for two-sample comparisons and oﬀers standard and novel visualizations for FCM data.
Statistical Methodology
The non-parametric Kolmogorov-Smirnoﬀ test (14) was used to evaluate the diﬀerence in the me-
dians of the FSC or SSC parameters between samples store in diﬀerent columns of a 96-well plate.
For each well the median value of the FSC and SSC parameters were calculated. The median values
were then grouped by columns and pairwise comparisons were done between columns or between
one column and the rest of the plate. The analysis was performed using the KS.test function
implemented in the rﬂowcyt package.
The Grubbs’ test (15) was used to test for two outliers on opposite tails of a sample. It is based
on the calculation of the ratio of the sample range to the sample standard deviation. For each
aliquots of each blood sample, taken over 6 time points before (-8 days) and after the graft (0, 5,
27, 39, 46 days), we calculated the median value of the FSC parameters and looked for outliers.
This analysis was performed using the R package outliers available at http://www.r-project.org.
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Results
One-dimensional summaries
In the GvHD dataset, given that at each time point one blood sample was divided in several aliquots,
the FSC distribution should be similar for every aliquot from the same sample. If the distribution of
one aliquot deviates from the others it should be identiﬁed and the corresponding aliquot should be
further investigated and potentially removed from any downstream analyses if no biological reasons
for the observed behavior can be ascertained. Other patterns, such as grouping of some aliquots,
would also warrant further investigation. ECDF plots were used to compare the distributions of
the FSC parameter for the diﬀerent aliquots of each patient, for each time point (Fig. 1). The
diﬀerent plots overlap except for one curve. In the example shown, at 46 days after transplantation,
one aliquot is substantially diﬀerent from the others. It presents only a few cells with forward light
scatter in the interval [0, 200] whereas in the other aliquots cells have a larger amount of cells in
that same interval. A Grubbs’ statistical test was also performed to test for outlying values. The
median values of the FSC parameter were calculated for each aliquot and the test was used to
detect whether the lowest and highest medians were outliers. The test identiﬁed the ﬁrst aliquot
of Day 46 as an outlying value (p-value<2.2−16) which supports the eﬀect we observed in Figure 1.
However the result also points out aliquots 3 and 4 at Day 39 which don’t appear to be problematic
in Figure 1. This suggests that caution should be exercised with respect to such statistical test as
it is for normal univariate distribution and our data highly deviate from normality. Nevertheless,
the observed eﬀect in Figure 1 seems to be a quality issue, likely a mislabeling of that particular
aliquot, and it should probably be removed from further analysis.
Likewise, we examined the intensity distributions of the CD molecules targeted by the phycoery-
thrin (PE) ﬂuorochrome for one patient across time points (Fig. 2). Changes in the subpopulations,
over time, will generally be reﬂected by changes in the observed ECDF plots. We believe that this
is observed for CD45, CD8beta and CD2. In cases where the graft had no eﬀect we expect to see
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no changes in the ECDF over time, e.g., CD20, TCRgamma-delta, CD25 and CD122. CD134 is
unusual, with a single very aberrant ECDF. The plot suggests very few low intensity observations
(since it is low and ﬂat up to an intensity of approximately 600), the other values are all below 600.
This could be biological, but it is also potentially an experimental artifact. Indeed its similarity to
the CD45 ECDFs, suggests a staining error, but clearly there are many other possible explanations.
In this comparison we expected to observe either some clear diﬀerences between time points,
indicating that the patient phenotype was evolving after the graft, or no diﬀerence, indicating that
the graft had no signiﬁcant eﬀect. We observed that the data varied for the ﬁrst three stains while
the other ﬁve presented similar distributions. However the targeted CD134 looks peculiar at 19
days after the graft as the ECDF curve clearly deviates from the other time points. Once again
this suggests an experimental bias as the curve looks similar to those from the ﬁrst panel, implying
a possible staining error.
Although ECDF plots reveal diﬀerences in distributions (Fig. 1), they are not good for visualizing
the shape or multimodality of a distribution. Unity normalized histograms are more appropriate
to visualize the asymmetry and the multimodal aspects of a distribution. Histogram plots were
then used to compare aliquots from a GvHD patient (Fig. 3) . Each aliquot was labeled to identify
a particular immune cell lineage of interest (e.g., natural killer, leukocyte). Often the same stain
was used in several aliquots which can be used as a basis for comparison. Figure 3 displays the
distributions of the intensities of that particular stain, for one patient at a given time point. In this
case we hypothesized to observe overlapping distributions for all the aliquots. Figure 3 shows in
fact that the majority of the distributions superimpose. However, two aliquots disagree with this
hypothesis. While the majority of the distributions are tri-modal (the ﬁrst mode representing dead
cells), one aliquot is clearly bimodal. Upon further investigation it was determined that this aliquot
was not properly stained. The second unusual distribution presents a shift to the left suggesting
that a lower concentration of antibodies was dispensed into the well during the staining procedure
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leading to a decrease in the intensity of ﬂuorescence.
Finally, another commonly used one-dimensional summary, to assess the quality of data, is the
boxplot representation. In the GvHD dataset, some samples were divided in 10 aliquots and scat-
tered between two plates. Figure 4 displays side-by-side boxplots of the 10 FSC measurements for
one patient, at one time point. In that case, plate eﬀects are noticeable by examining the height
of the boxplots. The FSC distributions look diﬀerent in the second plate for the days at the time
and after the graft. The spread of the FSC measurements is notably larger after the graft. This
phenomenon may be due to stickiness of the cells, which happens in some samples after freeze-thaw
procedures.
All three visualization approaches give diﬀerent views and each presents diﬀerent properties of
the distribution of the data. In fact, any graphical visualizations is good at presenting a few of
the many diﬀerent aspects of a dataset. Table 1 summarizes the properties and limitations of the
proposed methods. Visualizing those diﬀerent graphics together allows us to better investigate the
structure of the data, to search for artifacts and potentially their source. As an example, Figure
5 presents three diﬀerent one-dimensional views of a subset of the GvHD data. The ECDF plot
reveals only subtle diﬀerences in the lower hand of the distributions (Fig. 5A). The density plot
clearly shows that the data are bimodal (Fig. 5B). For example, the two population are asym-
metric, but have equivalent spread. The boxplot representation facilitates the comparison between
samples as they are horizontally aligned (Fig. 5C), however, we again note that the presence of
multimodality is completely obscured in these plots. We observe that the relative location of the
distributions and the shape are diﬀerent for the ﬁrst four samples (wells) compare to the four last.
Moreover the distribution of the data is more asymmetric in those last four wells as the median of
the samples seems to be closer to the upper quartile. Figure 5B shows that these eﬀects are largely
due to a higher content in cells at the left mode for these four aliquots.
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Two-dimensional summaries
While one dimensional summaries are useful, they do not tell the whole story. For example, some
samples will be normal with respect to either FSC or SSC, but will be unusual with respect to the
joint distribution. In the case of FC-HCS, one possible two-dimensional view is a scatterplot of
summary statistics such as the median, the mean, the mode or the IQR. The median is a resistant
measure of the middle of the distribution, but other statistical summaries could be more appropriate
as the median may be aﬀected by changes in measurements at the low end of the spectrum (e.g.,
the number of dead cells or other debris). The mean is often the most eﬃcient estimate of the
center of a distribution but can be adversely aﬀected by a few outlying values. The mode (or major
mode) is not often used but it is often more resistant to the spread of the distribution (i.e. long tails
and outliers) and its location is resistant to changes in mixtures of populations of cells, as seen in
Figure 5B. The mode is not necessarily unique as high frequency can be attained at diﬀerent values,
which in the case of FCM data usually correspond to diﬀerent populations of cells. Therefore, for
examining ungated data the mode might be a better choice than the mean or the median. IQR is a
reasonable summary of spread, but one could use others, such as the standard deviation or median
absolute deviation about the median.
Using scatterplots of descriptive statistics, we attempted to identify experimental artifacts in the
Rituximab dataset (2). In this experiment, every sample originated from a cell line and were stored
in 96-well plates with diﬀerent compounds. If the compounds have no eﬀect on the population of
cells the FSC versus SSC distribution for each aliquot should be similar. We chose the median
value for each of the FSC and SSC measurements as our summary statistics ( but other summaries
can be used) and we looked for plate speciﬁc eﬀects, such as edge eﬀects. Visually identifying plate
speciﬁc eﬀect can be achieved using diﬀerent color for each column (row), or using one color for
edge wells and a diﬀerent one for the interior wells. Then, in the plot, clustering of observations by
13
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color is suggestive of a problem. In Figure 6 the data points from the 11th column cluster at the top.
The same representation using the major mode as the summary statistic is slightly more variable
than when using the median (data not shown) but also detects the column eﬀect. We examined if
there was a diﬀerence between the medians (or modes) of the 11th column and the rest of the plate
using a Kolmogorov-Smirnov test. For the FSC channel the p-value, for testing both the median
and the mode were larger than α = 0.05. However for the SSC parameter, there is evidence of a
diﬀerence between the median of the 11th column and the medians of the rest of the plate with a
p-value=0.02. This plate speciﬁc eﬀect might be due to non-random compound dispersion to this
particular plate; in fact compounds included on this plate were speciﬁcally selected to eﬀect cell
cycle.
In that same Figure 6, we can also observed that while the majority of the samples fall in a
single group, samples A07 and E11 are far from the others. To further investigate those particular
aliquots, we make used of the two-dimensional contour plot method. Two-dimensional contour
plots of FSC versus SSC parameters were plotted for nine wells of the questionable plate, the two
outlier samples and seven randomly selected samples (Fig. 7). The ﬁgure shows that samples A07
and E11 have wider contour lines than the others. Sample A07 even shows two modes whereas
the others tend to be unimodal. In this case, the underlying cause was biological and not due to
quality issues. Samples A07 and E11 were identiﬁed as biological variants of interest in the analysis
performed by Gasparetto et al. (2).
Discussion & Conclusion
In this paper we have concentrated on one- and two-dimensional views to summarize ungated FCM
data. Table 1 summarizes their diﬀerent properties and limitations. We believe these plots are an
intuitive and good ﬁrst approach for quality assessment of high throughput FCM data. We also
understand that some of the samples identiﬁed by our proposed procedures will be anomalous for
14
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biological reasons, as in Figure 6. However the main thrust of this paper is the identiﬁcation of
problems in data quality. Any points identiﬁed are worth studying further, and some determination
as to whether the sample presents data quality issues or rather presents real biological signiﬁcance,
should be made.
When assessing the quality of any high throughput FCM experiment, one-dimensional sum-
maries should come ﬁrst. They allow us to display several samples together in one graphic, fa-
cilitating comparisons between groups. For example, Figure 1 presents ECDF plots of 8 FSC
measurements at 12 diﬀerent time points, for one patient. Any sample unusual in any one of these
plots should be further investigated. We also demonstrated that boxplots can help identify plate
speciﬁc biases (Fig. 4). The spacings between the diﬀerent parts of the box can help indicate
variance, skew and identify outliers. However, we note that in the context of ungated FCM data
the use of summary statistics (summary scatterplots or boxplots) might be problematic, since such
data are often mixtures of populations and thus give rise to multimodal distributions as revealed
by the density plots (Fig 3). In such cases the interpretation of most summary statistics is prob-
lematic and most will change depending on the mixture present, even when each sub-population
is unchanged and conversely they may change little even when the corresponding sub-populations
change substantially. Further research into developing good summary statistics for such data is
needed.
While analyzing samples stored in 96-well plates, one should look for row, column, plate eﬀects
etc (Fig.6 and Fig.7). On one hand, samples that are divided in aliquots should be compared for
any and all sensible comparisons, e.g., ECDF plots of FSC values across all replicates in Figure 1.
On the other hand, two-dimensional scatterplots should be used for comparisons across samples, as
shown in the scatterplot of summary statistics in Figure 6. Two or higher dimensional summaries
are usually more complex to visualize but they can reveal unusual samples that are not anomalous
in either one-dimensional projection (the same is true for higher dimensions). Contour plots or
other enhanced high density scatterplots could be used to further investigate a particular sample,
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as seen in Figure 7. However, they typically require separate plots for each sample and thus are
more diﬃcult to use and interpret.
In conclusion, artifacts from sample preparation, handling, variations in instrument parame-
ters or other factors may confound experimental measurements and lead to erroneous conclusions.
Methods designed to detect problematic samples are an important, yet diﬃcult, application. The
role of EDA and quality assessment is to provide knowledge that the data are as anticipated. We
found that coupling graphical representations together provides a useful approach for assessing the
quality of the data in high throughput experiments, as each plot highlights diﬀerent characteristics
of the data (Fig. 5 and Tab. 1) and can reveal substantial non-biological diﬀerences in samples.
Such screening tools are particularly valuable for high throughput technologies as they allow rapid
evaluation of a large number of samples. We thus propose that the described visualizations should
be used as quality assessment tools and used as quality control procedures where possible. It is
likely that some summaries can be developed and specialized to particular situations and settings
using interactive visualization tools like GGobi (16), which have an elegant interface with R via the
Rggobi package.
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Figure 1: ECDF plots of the FSC values for the aliquots (A1-A8) from one patient at diﬀerent time
points (GvHD experiment). Each panel corresponds to a particular time point, in days before or
after transplantation. In each panel, each curve represents one of the 8 aliquots obtained from the
blood sample of one particular patient. At day 46 after graft, the ECDF for aliquot A1 deviates
from the others; it should be investigated further.
18
http://biostats.bepress.com/bioconductor/paper11
CD marker intensity (log)
E
m
pi
ric
al
 C
um
ul
at
iv
e 
D
is
tr
ib
ut
io
n
0.0
0.2
0.4
0.6
0.8
1.0
CD45 CD8 beta CD2 CD20
0.0
0.2
0.4
0.6
0.8
1.0
0 200 400 600 800 1000
TCR gamma/delta
0 200 400 600 800 1000
CD25
0 200 400 600 800 1000
CD134
0 200 400 600 800 1000
CD122
Time points (days from bone marrow transplantation)
−8
5
0
12
19
27
32
39
46
53
60
67
Figure 2: ECDF plots of the intensities of the phycoerythrin (PE) parameter for the stains from one
patient, across time (GvHD experiment). Each panel corresponds to one particular CD molecule
(attached to a speciﬁc subpopulation of cells) targeted by the PE ﬂuorochrome. Inside a panel,
each curve represents a diﬀerent time point, in days before and after transplantation. The ECDF
for CD134 at 19 days dramatically deviates from the rest, suggesting a staining error.
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Figure 3: Unity normalized histogram plots of the intensities of one CD molecule targeted in
several aliquots of one particular sample to identify diﬀerent immune cell lineages of interest (GvHD
experiment). Each curve represents one particular aliquot of a sample at a particular time point.
The curves are multimodal. The ﬁrst mode represents dead cells. The other modes correspond to
diﬀerent populations of cells.
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Figure 4: Boxplots of the FSC parameter for the 10 aliquots obtained from one patient (GvHD
experiment). Each boxplot displays the three quartiles of the distribution. The whiskers extend
to 1.5 times the inter-quartile range. The central box of the plot extends from the ﬁrst (25%) to
the third (75%) quartile and encompasses the median (50%) of the data. Boxplots are colored
according to the plate location of the aliquot (grey: plate#1; white:plate#2) .
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Figure 5: Diﬀerent ways of viewing the 8 aliquots (A1-A8) of the same sample (GvHD experiment).
Each curve or boxplot represents one particular aliquot of a sample taken at one time point. (A)
The ECDF plot of the FSC values reveals subtle diﬀerences at the lower hand of the distributions;
(B) The density plot of the FSC intensities presents the multimodal aspect of the distributions; (C)
The boxplots of the FSC intensities show their asymmetries and their diﬀerences in location.
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Figure 6: Scatterplot of the median intensity values of the FSC versus SSC parameters for each
well of a 96-well plate (Rituximab experiment). The dots representing the median intensities of the
samples are colored according to their column position in the plate.
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Figure 7: Contour plots of the FSC versus SSC parameters for 9 wells of a 96-well plate (Rituximab
experiment). The title of each panel correspond to the well position in the plate. A07 and E11 are
the two previously described outlier wells while the other seven were randomly selected. The color
scale goes from light to dark according to the density of cells per well, from low to high respectively.
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